|
|
Volumn 3, Issue 5, 2007, Pages 755-767
|
|
The role of oseltamivir in the treatment and prevention of influenza in children
|
|
Author keywords
Influenza; Neuraminidase inhibitor; Oseltamivir; Pediatrics
|
|
Indexed keywords
4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID;
ADAMANTANE;
AMANTADINE;
ANTIBIOTIC AGENT;
ANTIVIRUS AGENT;
INACTIVATED VACCINE;
LIVE VACCINE;
OSELTAMIVIR;
PLACEBO;
RIMANTADINE;
SIALIDASE INHIBITOR;
ZANAMIVIR;
ABNORMAL BEHAVIOR;
AGE DISTRIBUTION;
CENTRAL NERVOUS SYSTEM DISEASE;
CHILD CARE;
CHILDHOOD MORTALITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DIARRHEA;
DISEASE PREDISPOSITION;
DOSAGE SCHEDULE COMPARISON;
DRUG COST;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG INDICATION;
DRUG METABOLISM;
DRUG RESPONSE;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
GENE MUTATION;
HEALTH CARE PLANNING;
HEALTH ECONOMICS;
HEART DISEASE;
HUMAN;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS A;
INFLUENZA VIRUS A H5N1;
INFLUENZA VIRUS B;
KIDNEY CLEARANCE;
MENTAL DISEASE;
NEUROLOGIC DISEASE;
NONHUMAN;
PANDEMIC;
RANDOMIZED CONTROLLED TRIAL;
RECOMMENDED DRUG DOSE;
RESPIRATORY TRACT DISEASE;
REVIEW;
STRUCTURE ACTIVITY RELATION;
TREATMENT DURATION;
UNSPECIFIED SIDE EFFECT;
VOMITING;
ANTIVIRAL RESISTANCE;
CHILD;
DRUG CONTROL;
EPIDEMIC;
QUALITY ADJUSTED LIFE YEAR;
ANTIVIRAL AGENTS;
CHILD;
DISEASE OUTBREAKS;
DRUG AND NARCOTIC CONTROL;
DRUG RESISTANCE, VIRAL;
HUMANS;
INFLUENZA, HUMAN;
OSELTAMIVIR;
QUALITY-ADJUSTED LIFE YEARS;
|
|
EID: 85047685240
PISSN: 17425255
EISSN: None
Source Type: Journal
DOI: 10.1517/17425255.3.5.755 Document Type: Review |
|
Times cited : (19)
|
|
References (87)
|
